OculoMotor Technologiesâ (OMT) is structured around bringing the latest technological advances to optometrists and vision therapists, thereby enabling them to provide improved clinical outcomes and engaging therapeutic experiences to patients with binocular vision disorders. With close ties of the principals to the New Jersey Institute of Technology, the firm combines virtual reality based vision therapy with on board eye tracking to provide therapeutic effect to patients suffering from convergence insufficiency. By integrating research-backed virtual reality assessments and therapies into their existing workflows, OMT is also enabling itheir acheieving increased revenue
